A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder

被引:5
|
作者
Diaz-Thomas, Alicia [1 ]
Cannon, John [2 ]
Iyer, Pallavi [3 ]
Al-Maawali, Almundher [4 ]
Fazalullah, Mohammed [4 ]
Diamond, Frank [3 ]
Mueller, O. Thomas [5 ]
Root, Allen W. [3 ]
Alyaarubi, Saif [4 ]
机构
[1] Univ Tennessee, Le Bonheur Childrens Hosp, Hlth Sci Ctr, Memphis, TN 38103 USA
[2] USF ACH, Childrens Res Inst, St Petersburg, FL USA
[3] All Childrens Hosp, Johns Hopkins Med, St Petersburg, FL USA
[4] Sultan Qaboos Univ Hosp, Muscat, Oman
[5] ACH Mol Genet Lab, St Petersburg, FL USA
来源
关键词
calcium sensing receptor (CaSR); familial/hereditary hypocalciuric hypercalcemia; neonatal hypercalcemia; neonatal severe hyperparathyroidism; CALCIUM-SENSING RECEPTOR; HYPERCALCEMIA; DOMAIN;
D O I
10.1515/jpem-2013-0343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Neonatal severe primary hyperparathyroidism (NSHPT, MIM 239200) is most often an isolated disorder that is due to biallelic inactivating mutations in the CASR, the gene encoding the calcium sensing receptor; NSHPT is inherited from parents with familial hypocalciuric hypercalcemia, each of whom has one mutated CASR allele. Objectives: To report clinical and genetic findings in a brother and sister with NSHPT due to a novel mutation in the CASR transmitted as an autosomal recessive trait and to examine the functional effect of the mutation. Subjects and methods: A brother and sister with marked hypercalcemia due to NSHPT were identified; the boy also had craniosynostosis requiring surgical repair. The genotyping of the CASR in both children and their parents who were eucalcemic and normophosphatemic was undertaken. In order to examine the significance of the variant CASR identified, the CASR variant was expressed in vitro and examined by three computer computational programs [PolyPhen2, MutationTaster, Sorting Intolerant From Tolerant (SIFT)] designed to evaluate the effect of a nucleotide variant on the structure and likely functional consequence upon the protein product. Results: A sequence variant in the CASR was identified [G>T point mutation at nucleotide c.2303 in exon 7 (c.2303G>T) resulting in the replacement of glycine by valine at codon 768 (p.Gly768Val)]. Two copies of this CASR variant were present in the genome of the siblings while a single copy of the CASR variant was present in both of the clinically and biochemically normal parents, a pattern of transmission consistent with autosomal recessive inheritance of NSHPT in this family. When expressed in HEK293 cells in vitro, the novel Gly768Val variant did not interfere with protein generation or migration to the cell membrane in vitro. The analysis of the functional effect of the Gly768Val CASR variant by the PolyPhen2, MutationTaster, and Sorting Intolerant From Tolerant computer programs revealed that this mutation was very likely to be deleterious. Conclusion: The NSHPT associated with biallelic Gly768Val mutations of the CASR in two siblings with severe hypercalcemia and hyperparathyroidism and their clinically and biochemically normal heterozygous parents was transmitted as an autosomal recessive disorder in this family.
引用
收藏
页码:851 / 856
页数:6
相关论文
共 50 条
  • [21] A novel connexin 26 mutation associated with autosomal recessive sensorineural deafness
    Frei, K
    Lucas, T
    Ramsebner, R
    Schöfer, C
    Baumgartner, WD
    Weipoltshammer, K
    Erginel-Unaltuna, N
    Wachtler, FJ
    Kirschhofer, K
    AUDIOLOGY AND NEURO-OTOLOGY, 2004, 9 (01) : 47 - 50
  • [22] Neonatal severe hyperparathyroidism with inactivating calcium sensing receptor (CaSR) mutation (p.I81K)
    Donbaloglu, Zeynep
    Gullu, Merve
    Tekin, Suat
    Karaguzel, Gungor
    Parlak, Mesut
    Tuhan, Hale
    Turkkahraman, Doga
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2025,
  • [23] Neonatal Severe Hyperparathyroidism due to Compound Heterozygous Mutation of Calcium Sensing Receptor (CaSR) Gene Presenting as Encephalopathy
    Abhishek Kulkarni
    Mahesh Mohite
    Ramaa Vijaykumar
    Prasanna Bansode
    Sachin Murade
    Parag M. Tamhankar
    The Indian Journal of Pediatrics, 2014, 81 : 1228 - 1229
  • [24] Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation
    Gulcan-Kersin, Sinem
    Kirkgoz, Tarik
    Eltan, Mehmet
    Rzayev, Turkay
    Ata, Pinar
    Bilgen, Hulya
    Ozek, Eren
    Bereket, Abdullah
    Turan, Serap
    HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 (05): : 313 - 321
  • [25] New mutation in the CASR in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe primary hyperparathyroidism (NSHPT) cases
    Cau, A. Arias
    Martin, R. Matsunga
    Bussmann, L.
    Insua, C.
    Pacin, M.
    Bastida, G.
    Correa, P.
    Brunetto, O.
    HORMONE RESEARCH, 2007, 68 : 1 - 2
  • [26] Neonatal severe hyperparathyroidism caused by homozygous mutation in CASR gene: A rare cause of life-threatening hypercalcemia
    Arif, Muzna
    Kirmani, Salman
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S83 - S83
  • [27] Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation
    Manuela Capozza
    Iolanda Chinellato
    Vito Guarnieri
    Natascia Di lorgi
    Maria Accadia
    Cristina Traggiai
    Girolamo Mattioli
    Antonio Di Mauro
    Nicola Laforgia
    BMC Pediatrics, 18
  • [28] Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation
    Capozza, Manuela
    Chinellato, Iolanda
    Guarnieri, Vito
    Di Iorgi, Natascia
    Accadia, Maria
    Traggiai, Cristina
    Mattioli, Girolamo
    Di Mauro, Antonio
    Laforgia, Nicola
    BMC PEDIATRICS, 2018, 18
  • [29] Neonatal Severe Hyperparathyroidism due to Compound Heterozygous Mutation of Calcium Sensing Receptor (CaSR) Gene Presenting as Encephalopathy
    Kulkarni, Abhishek
    Mohite, Mahesh
    Vijaykumar, Ramaa
    Bansode, Prasanna
    Murade, Sachin
    Tamhankar, Parag M.
    INDIAN JOURNAL OF PEDIATRICS, 2014, 81 (11): : 1228 - 1229
  • [30] Transient, neonatal severe hyperparathyroidism (NSHPT) in a newborn apparently heterozygous for the CASR mutation C562Y
    Thomassen, H
    Boman, H
    Hansen, TWR
    PEDIATRIC RESEARCH, 2003, 53 (04) : 408A - 408A